Kayne Anderson Rudnick Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3K Sell
334
-11,721
-97% -$636K ﹤0.01% 712
2026
Q1
$756K Buy
12,055
+11,724
+3,542% +$938K ﹤0.01% 398
2025
Q4
$31.6K Buy
331
+22
+7% +$2.16K ﹤0.01% 627
2025
Q3
$30.3K Buy
309
+5
+2% +$518 ﹤0.01% 635
2025
Q2
$32.8K Buy
304
+165
+119% +$16.7K ﹤0.01% 640
2025
Q1
$14K Sell
139
-51
-27% -$5.13K ﹤0.01% 672
2024
Q4
$17K Buy
190
+51
+37% +$4.49K ﹤0.01% 646
2024
Q3
$11.6K Sell
139
-13
-9% -$1.02K ﹤0.01% 665
2024
Q2
$11.7K Buy
152
+13
+9% +$952 ﹤0.01% 623
2024
Q1
$9.52K Buy
139
+20
+17% +$1.29K ﹤0.01% 632
2023
Q4
$6.88K Buy
119
+50
+72% +$2.67K ﹤0.01% 637
2023
Q3
$3.64K Hold
69
﹤0.01% 643
2023
Q2
$3.73K Buy
+69
New +$3.6K ﹤0.01% 640
2022
Q2
Sell
-157
Closed -$7K 613
2022
Q1
$7K Buy
157
+139
+772% +$6.02K ﹤0.01% 543
2021
Q4
$1K Buy
+18
New +$756 ﹤0.01% 602
2020
Q2
Sell
-50
Closed -$2K 552
2020
Q1
$2K Hold
50
﹤0.01% 520
2019
Q4
$2K Hold
50
﹤0.01% 552
2019
Q3
$2K Buy
+50
New +$2.12K ﹤0.01% 502

Other funds holding BSX

Kayne Anderson Rudnick Investment Management's BSX Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Boston Scientific (BSX) stake by 97% in Q2 2026, selling an estimated $636K and leaving 334 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #712.

Kayne Anderson Rudnick Investment Management first reported a position in BSX in Q3 2019 and has held it in 18 quarters since. The position peaked at $756K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 334 shares of Boston Scientific worth $14.3K as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 11,721 Boston Scientific shares in Q2 2026, an estimated $636K.
  • Boston Scientific made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #712 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Boston Scientific in Q3 2019 and has held it in 18 quarters since.
  • Kayne Anderson Rudnick Investment Management's Boston Scientific position peaked at $756K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.